Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1

Status

Unknown 1Terminated 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Polycystic Ovary Syndrome 152Breast Neoplasms 40Prostatic Neoplasms 31Insulin Resistance 30Obesity 23Neoplasms 15Endometrial Neoplasms 15Pancreatic Neoplasms 14Infertility 14Colorectal Neoplasms 13Carcinoma, Non-Small-Cell Lung 12Anovulation 10Lung Neoplasms 9Neoplasm Metastasis 8Hyperandrogenism 8Glioblastoma 8Diabetes Mellitus 8Squamous Cell Carcinoma of Head and Neck 7Metabolic Syndrome 7Melanoma 7Rectal Neoplasms 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Ovarian Neoplasms 5Lymphoma, Large B-Cell, Diffuse 5Head and Neck Neoplasms 5Brain Neoplasms 5Adenocarcinoma 5Weight Loss 4Uterine Cervical Neoplasms 4Urinary Bladder Neoplasms 4

Interventions

Metformin 2Saline Solution 1Lidocaine 1Injections, Intradermal 1Gels 1Cyproterone Acetate 1Cetuximab 1Adrenal Cortex Hormones 1Adalimumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Acne Vulgaris × Metformin × Clear all
NCT02500147 2025-07-02

Metformin for Ectopic Fat Deposition and Metabolic Markers in Polycystic Ovary Syndrome (PCOS)

Columbia University

Phase 4 Terminated
3 enrolled 5 charts

Acne Vulgaris, Amenorrhea, Hirsutism, Polycystic Ovary Syndrome, Metabolic Syndrome, Dyslipidemias, Non-alcoholic Fatty Liver Disease

NCT02198417 2018-08-16

Metformin Treatment in Polycystic Ovary Syndrome (PCOS)

Massachusetts General Hospital

Phase NA Unknown
20 enrolled

Acne Vulgaris, Infertility, Menstruation Disturbances, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡